Senior Director, Neurobiology - Waltham, United States - Dragonfly Therapeutics

Description

Senior Director, Neurobiology

Dragonfly seeks an experienced and motivated neurobiologist to drive target identification/validation and proof of concept studies in neuropathic pain and other neurologic conditions/diseases. The successful candidate will be a strong scientist with hands-on familiarity with neurobiology techniques, early discovery biopharmaceutical experience and a proven track record of reducing innovation to practice. The individual will report to the CSO.

Responsibilities:

• Apply experience and expertise to lead proof of concept studies for novel therapies in neuropathic pain and other neurologic diseases/conditions
• Identify and validate relevant molecular targets for intervention using internal resources and CROs
• Recruit and lead a small team to build and utilize in vitro and in vivo preclinical model systems for proof of concept studies as well as downstream drug candidate screening
• Collaborate effectively with translational, clinical, regulatory, business and other scientific colleagues to drive cross-functional opportunity assessment; present and articulate proposed innovation strategies to Senior Management and Scientific Advisory Board
• Coordinate preparation and review of laboratory documentation, study reports and project presentations
• Manage neurobiology budget to ensure a disciplined allocation of resources to high yield areas
• Assume responsibility and ensure that corporate goals relevant to your team are met in a timely manner
• Be a role model for Dragonfly's culture and values; act as a cultural ambassador for the company

Qualifications:

• Ph.D. degree in neurobiology, neuroimmunology, neuroscience or related field
• 10+ years of industry experience in biopharmaceutical setting
• Strong understanding of central and peripheral nervous systems as well as disorders and diseases impacting them
• Broad and deep experience in exploring novel product concepts for neurological conditions and disease with high unmet need
• Deep experience in target idenfitication, validation and preclinical proof of concept studies with antibodies or other protein-based therapies for the treatment of neurologic conditions and diseases
• Hands-on experience with in vitro and in vivo preclinical model systems, techniques and resources for conditions/diseases impacting both PNS and CNS
• Proven track record in scientific leadership and project and team management in both line and matrix settings
• Adept in preparation and implementation of project plans created with input by cross-functional subject matter experts
• Strong verbal and written communication skills; ability to clearly articulate scientific viewpoints to diverse audiences and engage them into debate with a view of gaining a broader perspective
• Self-motivated, conscientious, and passionate about improving patients' lives

About Dragonfly

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas.

Our mission is to revolutionize disease treatment by inventing natural killer cell-based therapies for vastly improved patient outcomes. We believe in a small team with a big impact.